SCHEMBL10269367

SCHEMBL10269367

COc1ccc(-c2ccc3cn[nH]c3c2)cn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 10/20 0.55
PIK3CA P42336 4/20 0.54
PIK3CD O00329 3/20 0.54
PIK3CB P42338 3/20 0.54
PIK3CG P48736 3/20 0.54
FGFR2 P21802 4/20 0.54
FGFR3 P22607 2/20 0.54
CHEK1 O14757 2/20 0.52
PLK4 O00444 1/20 0.52
PDPK1 O15530 1/20 0.52
DYRK3 O43781 1/20 0.52
JAK2 O60674 1/20 0.52
ROCK2 O75116 1/20 0.52
PRKD3 O94806 1/20 0.52
MAP4K4 O95819 1/20 0.52
ABL1 P00519 1/20 0.52
NTRK1 P04629 1/20 0.52
INSR P06213 1/20 0.52
FYN P06241 1/20 0.52
CDK1 P06493 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28737629 0.80 PIK3CD (0.41) FGFR1PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL28104327 0.80 FGFR1 (0.65) FGFR1PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL7089345 0.79 MAP3K11 (0.56) FGFR1PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL14404415 0.76 FGFR1 (0.68) FGFR1PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL31174412 0.76 CYP2A6 (0.68) PIK3CAPIK3CDPIK3CBPIK3CGFYN
SCHEMBL3754419 0.76 CYP2A6 (0.68) PIK3CAPIK3CDPIK3CBPIK3CGFYN
SCHEMBL13115655 0.74 FGFR1 (0.71) FGFR1PIK3CDPIK3CBFGFR2FGFR3
SCHEMBL5252959 0.73 FGFR1 (0.51) FGFR1PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL7328650 0.73 MAP3K11 (0.70) PIK3CAPIK3CDPIK3CBPIK3CGDYRK3
SCHEMBL7273777 0.72 LOXL2 (0.61) PIK3CAPIK3CDPIK3CBPIK3CGMKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053345-A1 Indazole Compounds ABBOTT LABORATORIES (US) 2012-03-01 US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070282101-A1 Indazole compounds CYP3A43, CYP3A7, UGT1A1 FGFR1 524/4885PIK3CA 979/4885PIK3CD 1488/4885
US-20120053345-A1 Indazole Compounds CYP3A43, CYP3A7, UGT1A1 FGFR1 524/4885PIK3CA 979/4885PIK3CD 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.